In this diverse cohort study of 1500 children, the trajectory of cardiovascular health scores began to decline at around age 10, associated with health behaviors rather than health factors.
Vaccine effectiveness of 52.8% seen for ED visits, 52.3% for noncritical hospitalization, 50.4% for critical hospitalization.
Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within 5 years before diagnosis, according to a study publi ...
Our work suggests that targeting the brain-muscle axis could offer new treatment strategies for muscle fatigue.
Our work suggests that targeting the brain-muscle axis could offer new treatment strategies for muscle fatigue.
HealthDay News — The prevalence of post-COVID-19 condition (PCC) was 8.4% among US adults in 2023, according to a research letter published online in JAMA Network Open.
Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
CagriSema-treated patients achieved superior weight loss compared with those who received cagrilintide 2.4mg, semaglutide 2.4mg or placebo. Topline data were announced from a phase 3 trial ...
The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback